| #60 |
Peter David Cron |
Novartis Ag |
1 |
| #60 |
Per Rigler |
— |
1 |
| #60 |
Reto Brun |
Georgia State University |
1 |
| #60 |
Martin Kesselgruber |
Solvias Ag |
1 |
| #60 |
Anne F. Mayer |
Dsm Ip Assets B.V. |
1 |
| #60 |
Peter Simmendinger |
Basf Se |
1 |
| #60 |
Jacques Herzog |
Ballard Power Systems |
1 |
| #60 |
Andreas Maunz |
Hoffmann-La Roche |
1 |
| #60 |
Marius Hoener |
Hoffmann-La Roche |
1 |
| #60 |
Alain Dürr |
Fisher Clinical Services Gmbh |
1 |
| #60 |
Simona Cotesta |
Novartis Ag |
1 |
| #60 |
Nicole Buschmann |
Novartis Ag |
1 |
| #60 |
Yaakov Benenson |
Eth Zurich |
1 |
| #60 |
Oliver Simic |
Novartis Ag |
1 |
| #60 |
Bernhard Wietfeld |
Novartis Ag |
1 |
| #60 |
Ulrich Mundwiler |
Straumann Holding Ag |
1 |
| #60 |
Anette Von Matt |
Novartis Ag |
1 |
| #60 |
Geraint Davies |
Hoffmann-La Roche |
1 |
| #60 |
Markus Rudolph |
Hoffmann-La Roche |
1 |
| #60 |
Johanne Renaud |
Novartis Ag |
1 |
| #60 |
Raphael Beumer |
Dsm Ip Assets B.V. |
1 |
| #60 |
Frank Stowasser |
Novartis Ag |
1 |
| #60 |
Franz Brandl |
Syngenta Crop Protection Ag |
1 |
| #60 |
Rosa Maria Rodriguez Sarmiento |
Hoffmann-La Roche |
1 |
| #60 |
Pierre De Meuron |
— |
1 |
| #60 |
Nigel Graham Cooke |
Novartis Ag |
1 |
| #60 |
Johannes Tschumi |
Dsm Ip Assets B.V. |
1 |
| #60 |
Stephan Buchmann |
Actelion Pharmaceuticals |
1 |
| #60 |
Philipp Floersheim |
Novartis Ag |
1 |
| #60 |
Mario Gago |
Depuy Synthes Products |
1 |
| #60 |
Moise Azria |
Novartis Ag |
1 |
| #60 |
Peter Gedeck |
Novartis Ag |
1 |
| #60 |
Mathias Frederiksen |
Novartis Ag |
1 |
| #60 |
Heinz Stadler |
Hoffmann-La Roche |
1 |
| #60 |
Paul Goldsmith |
F. Hoffmann-La Roche Ag |
1 |
| #60 |
Petra Herzig |
Eberhard Karls Universität Tübingen |
1 |
| #60 |
Rolf Baenteli |
Novartis Ag |
1 |
| #60 |
Mamadi Keita |
Endress+Hauser Flowtec Ag |
1 |
| #60 |
Duncan McKenzie |
Syngenta Crop Protection Ag |
1 |
| #60 |
Pirmin Hidber |
F. Hoffmann-La Roche Ag |
1 |
| #60 |
Helga Steinfatt |
— |
1 |
| #60 |
Valerie Quesniaux |
Novartis Ag |
1 |
| #60 |
Jean-Marc Groell |
Novartis Ag |
1 |
| #60 |
Acyr Avila da Luz Neto |
Accenture Global Services Limited |
1 |
| #60 |
Beat Michael Aebli |
Ciba Specialty Chemicals |
1 |
| #60 |
Sergio Wittlin |
Medicines For Malaria Venture |
1 |
| #60 |
Markus Hemminger |
F. Hoffmann-La Roche Ag |
1 |
| #60 |
Daniel E. Gerard |
Omya International Ag |
1 |
| #60 |
Hans Reichert |
Ciba Specialty Chemicals |
1 |
| #60 |
Maxime Gaillot |
Hoffmann-La Roche |
1 |